Meperidine / pethidine (injection)
پتیدین (مپریدین، تزریقی)
🧠 Nervous SystemOpioid analgesic
Market / country: 🇺🇸 USA
Demerol (US)
🧮 Dose calculator
Severe pain requiring an opioid · Regimen source: FDA Meperidine inj. · 2.2
- • Titrate to response. Label pediatric dose: 0.5–0.8 mg/lb (about 1.1–1.8 mg/kg) up to the adult dose — but the label says safety below 18 is not established. FDA Meperidine inj. · 2.2FDA Meperidine inj. · 8.4
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Significant respiratory depression; acute asthma; GI obstruction; MAO inhibitor within 14 days (fatal reactions); hypersensitivity. FDA Meperidine inj. · 4FDA Meperidine inj. · Boxed Warning
Warnings
- • Boxed warning: addiction, respiratory depression, neonatal withdrawal, benzodiazepine and MAOI interactions. Normeperidine accumulates in renal impairment and can cause seizures. FDA Meperidine inj. · Boxed WarningFDA Meperidine inj. · 5
Important interactions
- • Contraindicated with MAO inhibitors (coma, respiratory depression, serotonin syndrome). FDA Meperidine inj. · Boxed Warning
Formulations
- 50 mg/mL vial — injection 🇺🇸 USA FDA Meperidine inj. · 3
- 25 mg/mL vial — injection 🇺🇸 USA FDA Meperidine inj. · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Meperidine inj. · Boxed Warning
“If opioid use is required for an extended period of time in a pregnant woman, advise the patient of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Meperidine inj. · 8.2
“Risk Summary Meperidine appears in the milk of nursing mothers receiving the drug.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Meperidine inj. · 8.4
“The safety and efficacy of Meperidine Hydrochloride Injection in patients less than 18 years of age have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Meperidine inj. · 8.5
“In general, use caution when selecting a dosage for an elderly patient, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Meperidine inj. · 8.3
“Infertility Use of opioids for an extended period of time may cause reduced fertility in females and males of reproductive potential.”
🔗 Reference links
- FDA (approval record)ANDA080445
- DailyMed (FDA label)FDA Meperidine inj.
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDN02AB02
- Darooyab (Iran)Pethidine
🇮🇷 Registered in Iran Darooyab · G-156/Pethidine
Dosage forms with Iranian generic codes, per Darooyab.
- 01355 · PETHIDINE HCL 100MG/2ML AMP · آمپول پتیدین هیدروکلراید ۱۰۰ میلیگرم / ۲ میلیلیتر
- 11397 · PETHIDINE HCL 25MG/1ML 1ML AMP · آمپول پتیدین هیدروکلراید ۲۵ میلیگرم / ۱ میلیلیتر ۱ میلیلیتر
- 01354 · PETHIDINE HCL 50MG/1ML AMP · آمپول پتیدین هیدروکلراید ۵۰ میلیگرم / ۱ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Meperidine inj. · 3FDA Meperidine inj. · 2.2FDA Meperidine inj. · 8.4FDA Meperidine inj. · 4FDA Meperidine inj. · Boxed WarningFDA Meperidine inj. · 5FDA Meperidine inj. · 8.2FDA Meperidine inj. · 8.5FDA Meperidine inj. · 8.3FDA Meperidine inj. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-156/Pethidine
- Clinical review⚠ Unverified